A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy
Clinical trial NCT05877040 · UNKNOWN
Trial details
- NCT number
- NCT05877040
- Sponsor
- Istituto Clinico Humanitas
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2023-03-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.